Inventor · disambiguated record
Jae-Hun Kim
Also filed as: KIM JAE-HUN
7 granted patents·3 pending applications·13 citations·filing 2009–2022
76Inventor score
Top patents by PatentIndex Score
10 records- 0183US9555038B2Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·6 cites·24 claims
- 0281US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 0377US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 0473US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 0564US9808473B2Preparation and use of 3-pyridyl substituted-6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·0 cites·13 claims
- 0653US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 0752US2011224193A1Inhibitors of diacylglycerol acyltransferaseMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 0847US8716312B2Inhibitors of diacylglycerol acyltransferaseTING PAULINE C·Filed 2009·Granted May 6, 2014·0 cites·6 claims
- 0941US10646494B2Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2017·Granted May 12, 2020·0 cites·16 claims
- 1038US2020069691A1Heterocyclic compounds as hiv protease inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jae-Hun Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →